Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer

BACKGROUND. Mesothelin is overexpressed in many solid tumors, and recent studies have shown that mesothelin expression is associated with poor outcomes in several malignant tumors and may play a role in cancer progression. Clinical trials of mesothelin‐targeted immunotherapies are currently under wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Shin, Su‐Jin, Park, Sejung, Kim, Min Hwan, Nam, Chung Mo, Kim, Hyunki, Choi, Yoon Young, Jung, Min Kyu, Choi, Hye Jin, Rha, Sun Young, Chung, Hyun Cheol
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853112/
https://ncbi.nlm.nih.gov/pubmed/31015316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0896
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados